Clinical Trial Title
The purpose of this study is to test whether the drug Glucophage® XR (generic name metformin extended-release tablets) can prevent cognitive decline among persons with mild cognitive impairment.National Clinical Trial Number:
NCT04098666Contact Information
Clinical Trial Protocol Description:
The purpose of this study is to test the efficacy of the drug Glucophage® XR Metformin (generic name metformin extended-release tablets) in the prevention of cognitive decline associated with Alzheimer’s dementia. Nationwide, 370 participants will be recruited for this study at 11 sites across the United States. At Rush University Medical Center, we expect to recruit up to 30 participants.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Be 55-90 years old.
- Have a diagnosis of MCI or a subjective memory complaint.
- You have not been diagnosed with diabetes or dementia.
- Have an individual who knows you well willing to take part in the study with you as your study partner.
This is a partial list of inclusion and exclusion criteria.
Study Details
Clinical Trial Investigator
Zoe Arvanitakis, PhD
Contact Information
Michael Pessman
Clinical Trial Location
RUSH University Medical Center